A history of painful, blistering, or severe #sunburn is linked with increased odds of developing #cutaneousSquamousCellCarcinoma. Published in @jamadermatology.com.#sunburn#cutaneousSquamousCellCarcinoma https://bit.ly/3M7FSfX #CSCC #carcinoma

Women aged younger than 50 years with a high consumption of ultraprocessed foods are more likely to develop early-onset conventional adenomas, a precursor to #colorectalcancer. From @jamaoncology.com.#colorectalcancer https://bit.ly/43EpN7G #crcsm

Having more liver fat is linked to an increased risk of recurrence and worse survival among patients with stage I-III #coloncancer. Published in the journal of the National Cancer Institute. https://bit.ly/3LMUVvw #gicsm

Dr Burtness shares some of her key takeaways in #headandNeckCancer from @myesmo.bsky.social#headandNeckCancer#ESMO2025. https://bit.ly/48j1vTk #hncsm #HNC

Black women with epithelial #ovariancancer who took acetaminophen daily or regularly for more than 5 years appeared to have an increased risk for all-cause mortality. https://bit.ly/499Yt4L #gyncsm

Following changes in #colorectalCancer screening guidelines, facility-based screening among adults aged 45 to 49 years increased nearly ten-fold. Published in @jamanetworkopen.com.#colorectalCancer https://bit.ly/49eFeag #crcsm

#Oncology clinical #practiceguidelines from the NCCN lack specificity about #cancerSurveillance for patients treated with curative intent. Published in @jamanetworkopen.com.#Oncology#practiceguidelines#cancerSurveillancehttps://bit.ly/47LozbW

#Prostatecancer misinformation is common across the 3 most popular social media networks—TikTok, Instagram, and YouTube—in both English and Spanish, according to findings newly published online in @lungusa.bsky.social#Prostatecancer https://bit.ly/4p3Fihy #pcsm

An AI-based imaging analysis could serve as an aid in surgical planning for patients with kidney tumors, according to research presented at #IKCSNA25. shorturl.at/p7Z9q

A method to address discrepancies between predicted biological age and actual chronological age has been validated as a potential biomarker in predicting OS in kidney cancer, researchers report at #IKCSNA25. shorturl.at/EKpfE

An AI-based model for analyzing images is better able to predict clear cell renal cell carcinoma from CT-based images than a tumor size-based model is, suggests research from #IKCSNA25. shorturl.at/dLeIV

Current risk stratification models perform well in assessing postoperative recurrence risk in patients with non-clear cell renal cell carcinoma, according to research presented at #IKCSNA25. shorturl.at/mdL1U

After nephron-sparing ablation therapy or partial nephrectomy, RCC patients who had local recurrence had a higher mortality risk than patients without recurrence, researchers reported at #IKCSNA25. shorturl.at/YAYwX

In patients with #RCC, greater abdominal adiposity and lower skeletal mass are associated with aggressive pathology, according to research presented at #IKCSNA25. shorturl.at/etqJT

Weight loss after localized #RCC diagnosis may be a marker for disease progression and worse prognosis, researchers report at #IKCSNA25. shorturl.at/c4Flx

Long-term data show higher-stage chRCC patients have worse outcomes than those with lower-stage chRCC, oncocytoma, or ORNLMP, according to research presented at #IKCSNA25. shorturl.at/c54by

More than a quarter of patients with #RCC on active surveillance experience spontaneous tumor regression, according to research presented at #IKCSNA25. shorturl.at/R9lKl

Cabozantinib has shown efficacy in the treatment of #RCC with non-locally pretreated brain metastases, according to research presented at #IKCSNA25. shorturl.at/Yq37E

Beginning statin therapy within 36 months of #breastcancer diagnosis is linked to improved survival for patients with early-stage disease, compared to patients who do not use statins. Published in @jamanetworkopen.com.#breastcancer https://bit.ly/4p5ThUd #bcsm

In #melanoma patients, the presence of tumor-infiltrating lymphocytes in pretreatment samples, detected using an AI-based tool, is associated with outcomes with ICI therapy. Published in @jamaoncology.com.#melanoma https://bit.ly/43uCx0C #melsm #skcsm

In the US, the 5-year survival rate for people diagnosed with #lungcancer has risen to 29.7%, according to the 2025 State of Lung Cancer report recently released by the @lungusa.bsky.social.#lungcancer https://bit.ly/488Fsi0 #lcsm #LungCancerAwarenessMonth #LCAM

When treated with ICIs, #cancer patients with a pre-existing anxiety diagnosis appear to experience more irAEs and have better OS than those without anxiety. https://bit.ly/4oyNfLQ #adverseEvents

Physical activity, particularly at a consistent level in line with guideline recommendations, significantly reduces both risk of and mortality from digestive system #cancers. Published in @jamaoncology.com.#cancers https://bit.ly/3WDdULm #gicancer #gicsm

Few LGBTQ+ #cancersurvivors received tailored survivorship care plans and other specialized resources even though their sexual orientation and gender identity was known to the care team. Published in @jamanetworkopen.com.#cancersurvivors https://bit.ly/4oKrNTY #LGBTQCancer #LGBTOnc

Adding a phytochemical-rich food supplement to active surveillance appeared to slow progression of prostate-specific antigen and improve urinary symptoms among men with low-risk #prostatecancer. Published in @eururoloncol.bsky.social#prostatecancer https://bit.ly/3JKQdxJ #pcsm

Physical activity, particularly at a consistent level in line with guideline recommendations, significantly reduces both risk of and mortality from digestive system cancers. Published in @jamaoncology.com https://bit.ly/3WDdULm #gicsm #gicancer #GastricCancerAwaressMonth ##GCAM

Read more about these exciting #oncology updates from #NANETS25 with Daneng Li from @cityofhope.bsky.social here: ▶️https://bit.ly/3JIMaSy #cancerResearch

Although the average time to treatment for early-stage breast, cervical, or ovarian #cancer is less than 1 month in many high-income countries, treatment can take 4 months to a year in some low- and middle-income countries. Published in @thelancet.com.#cancer https://bit.ly/49yqPWj #gyncsm #bcsm

Phase 3 data from multiple studies presented at #ESMO25 demonstrated that novel staging approaches along with new therapy combinations, such as EV plus pembrolizumab and disitamab vedotin plus toripalimab improved SO in patients with #bladdercancer. https://bit.ly/4qMWKsC #blcsm #UroOnc

Researchers have identified a pattern of longer OS in patients with stage IV rectal small cell carcinoma than among patients with stage IV colon SCC. Presented at #NANETS25. https://bit.ly/3LeExUi #gicsm

Adjuvant T-DXd can improve outcomes when compared to T-DM1 in patients with high-risk, HER2-positive early #breastcancer who have residual invasive disease. Presented at #ESMO2025. https://bit.ly/4hAhkIk #bcsm #ESMO25

The risk of #lungcancer varies among responders involved in rescue and recovery after the collapse of the World Trade Center on September 11, 2001. Published in @jamanetworkopen.com.#lungcancer https://bit.ly/4nnFveb #lcsm #LCAM #LungCancerAwarenessMonth

CTC levels are an independent prognostic factor for patients with transplant-eligible, newly diagnosed #multipleMyeloma who were treated with a standard-of-care quadruplet regimen. Published in @bloodjournals.hematology.org#multipleMyeloma https://bit.ly/4ovLEqp #mmsm

Researchers say they have identified several factors that can be used to better predict the risk of #breastcancer among women. Findings reported in @jamaoncology.com.#breastcancer https://bit.ly/3JlYhol #bcsm #BCAM #BreastCancerAwarenessMonth

The TROP2 ADC sac-TMT improved survival, compared with platinum-based chemotherapy, in patients with EGFR-mutated NSCLC who had progressed on EGFR-targeted TKIs. Presented at #ESMO25. https://bit.ly/3LeE8Bl #lcsm #ESMO2025

Adjuvant T-DXd can improve outcomes when compared to T-DM1 in patients with high-risk, HER2-positive early #breastcancer who have residual invasive disease. Presented at #ESMO2025. https://bit.ly/4hAhkIk #bcsm #BCAM #BreastCancerAwarenessMonth

The association between sedentary time and #breastcancer varies by menopausal status, researchers found. https://bit.ly/3WdLAyW #bcsm #BCAM #BreastCancerAwarenessMonth

177Lu-edotreotide can improve PFS when compared to everolimus in patients with grade 1-2 GEP-NETs, according to a study presented at #NANETS2025 by Dr Jaume Capdevila of @vhio.bsky.social. www.cancertherapyadvisor.com/reports/177l...

PRRT retreatment is well tolerated and confers a survival benefit in patients with well-differentiated, metastatic NETs, according to a study presented at #NANETS2025. www.cancertherapyadvisor.com/reports/prrt...

Ibrutinib plus rituximab had superior PFS when compared to chemoimmunotherapy among older patients with previously untreated #MCL. Published in @thelancet.com.#MCL https://bit.ly/3JoR9aT #lymsm

A risk of recurrence of less than 0.5% at 6 years after surgery may provide a practical definition of “cure” in the setting of #coloncancer. Published in @jamaoncology.com.#coloncancer https://bit.ly/47koJH9 #crcsm

In older #cancer patients, receiving federal housing assistance is associated with earlier-stage diagnosis of breast cancer, colorectal cancer, and NSCLC. Published in @jamanetworkopen.com#cancer https://bit.ly/3WNRwyN #bcsm #crcsm #lcsm #BreastCancerAwarenessMonth

#Oncologist coverage across the US has declined in recent years, leading to care gaps. Published in @ascopost.bsky.social#OncologistJCO Oncology Practice. https://bit.ly/3WhLIxs #cancerCare

Researchers say they have identified several factors that can be used to better predict the risk of #breastcancer among women. Reported in @jamaoncology.com.#breastcancer https://bit.ly/3JlYhol #bcsm #BreastCancerAwarenessMonth #BCAM

#SmokingCessation after #cancer diagnosis is linked to improved OS even for advanced cancers. https://bit.ly/4qkWjVZ

In MIBC patients, ctDNA-guided, adjuvant atezolizumab treatment is associated with significant survival improvements over placebo. Presented at #ESMO25 by Dr Thomas Powles of @qmul.bsky.social. #blcsm #gucsm #ESMO2025 shorturl.at/J32bd

Adjuvant ensartinib improves disease-free survival compared to placebo following complete resection of ALK-positive NSCLC, according to research presented at #ESMO25. #lcsm #ESMO2025 shorturl.at/XHWQh

Adjuvant cemiplimab may reduce the risk of second primary tumors in patients with high-risk cutaneous squamous cell carcinoma, data suggest. Presented at #ESMO25 by Dr Danny Rischin of @petermaccc.bsky.social. #skcsm shorturl.at/dZdi8

Long preoperative chemo elicited more pathologic complete responses than short preoperative chemo in PDAC, but no difference in EFS was seen. Presented at #ESMO25 by Dr Michele Reni of San Raffaele Scientific Institute. #gicsm #pancsm #esmo2025 shorturl.at/cPimQ

First-line treatment with disitamab vedotin plus toripalimab could be a new standard for patients with HER2-expressing, locally advanced or metastatic urothelial carcinoma, according to Dr Jun Guo, who presented these results at #ESMO25. #gucsm #blcsm #ESMO2025 shorturl.at/gyhIS